Over the past few decades, advances in the study and treatment of this inflammatory bowel disease have rapidly accelerated. We spoke to the experts to learn the latest about managing Crohn's disease—and what other potential breakthroughs are on the horizon.
Johnson & Johnson's Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That's where he met Tiko Kerr, who became one of the first patients to take the company's HIV medicines—and has thrived to this day. Watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video, filmed for AIDS 2022, the annual International AIDS Conference.
For Pride Month, Lynn Discenza shares her transition journey and how gender-affirmation surgery helped her reclaim her confidence and be who she's always wanted to be. Plus, learn how Johnson & Johnson MedTech is working to help ensure more people have access to the life-changing procedure.